EIT Pharma
PrivateLast Round
Series A
Aug 31, 2026
Total Funding Raised
$35M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
EIT Pharma is a biotechnology company that develops therapies for infectious diseases, including treatments for chronic hepatitis D and acute respiratory infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EIT Pharma Comparables
Compare EIT Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai Hepu Pharmaceutical Co., Ltd. | 79% | |
| Huahui Health Ltd. | 78% | |
| Mirum Pharmaceuticals | 78% |
EIT Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 31, 2026 |
EIT Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kayne Anderson Capital Advisors | Series A |
| Propel Bio Partners | Series A |
| Good Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 31, 2026
$35M round led by Propel Bio Partners.
Recent news
Latest coverage and updates
- receives_financingAug 31, 2026
EIT Pharma, Inc. received financing of $35M in Series A on Aug 31st '26.
EIT Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about EIT Pharma's valuation, stock price, and market status.
Is EIT Pharma a public or private company?
EIT Pharma is a private company.
What is the current stock price of EIT Pharma?
EIT Pharma is a private company with no public stock price. Caplight tracks EIT Pharma's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is EIT Pharma worth (valuation)?
Valuation information for EIT Pharma is not publicly available.
Can I buy EIT Pharma stock?
EIT Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was EIT Pharma's last funding round?
EIT Pharma's most recent funding round was Series A on August 31, 2026.
Who are the main investors in EIT Pharma?
Key investors in EIT Pharma include Propel Bio Partners.
Will EIT Pharma IPO soon?
No public IPO plans have been announced for EIT Pharma.
How can I track EIT Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EIT Pharma's secondary market activity and sign up for updates.